Oftaquix sine, 5 mg/ml, eye drops, solution in a single-dose container
Levofloxacin
Levofloxacin is an antibiotic belonging to a group called fluoroquinolones (sometimes shortened to quinolones). The medicine works by killing certain types of bacteria that can cause infections.
Levofloxacin in the form of eye drops is used in children from 1 year, adolescents, and adults to treat bacterial infections of the front surface of the eye.
One type of infection in this area is bacterial conjunctivitis, which is an infection of the outer layer of the front of the eye (conjunctiva).
Oftaquix sine should not be used in children under one year of age.
If there is no improvement or the patient feels worse after 5 days, they should consult a doctor.
In case of doubt, consult a doctor or pharmacist.
Before starting to use Oftaquix sine, discuss it with a doctor, pharmacist, or nurse
Swelling and tendon rupture have occurred in people taking fluoroquinolones orally or intravenously, especially in older patients and those treated with corticosteroids at the same time.
Treatment with Oftaquix sine should be discontinued if pain or swelling of the tendon (tendinitis) occurs.
Special warnings and precautions for the use of the medicine are the same for adults, adolescents, and children over one year of age.
Tell a doctor or pharmacist about all medicines the patient is taking or has recently taken, as well as any medicines planned to be used.
Particularly, tell a doctor or pharmacist about using any other eye drops or ointments before starting to use Oftaquix sine.
If the patient is using other eye drops, wait at least 15 minutes between administering Oftaquix sine and other eye drops.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Oftaquix sine may be used in pregnant women only if the expected benefit outweighs the potential risk to the fetus.
Levofloxacin penetrates into the blood and breast milk of women in very small amounts; after using eye drops, the likelihood of harming the developing child is very low.
The doctor is informed about the potential risk and will advise the patient whether to use Oftaquix sine eye drops in such a situation.
Oftaquix sine may be used during breastfeeding only if the expected benefit outweighs the potential risk to the breastfed child.
When using Oftaquix sine according to the recommendations, fertility (the ability to become pregnant or father a child) is not impaired.
Oftaquix sine has a negligible influence on the ability to drive and use machines.
If the eye drops cause blurred vision, the patient should wait until their vision is clear before driving or operating machines.
This medicine should always be used exactly as advised by a doctor or pharmacist. If in doubt, consult a doctor or pharmacist.
Oftaquix sine eye drops are intended for use in the eye and must be applied to the outer surface of the eye.
For patients over 1 year of age, the recommended dose is:
DAYS 1-2
DAYS 3-5
In elderly patients, modification of the recommended dose is not necessary.
Treatment usually lasts for five days. A doctor will inform the patient how long to use the drops.
If the patient is using any other eye medicine, wait at least 15 minutes between administering different types of eye drops.
There is no need to modify the dose in children over one year of age and adolescents. Oftaquix sine should not be used in children under one year of age.
If possible, ask another person to administer the drops. Before administering the drops to the patient, ask them to read these instructions to the patient.
| ![]() |
| ![]() |
| ![]() |
| ![]() |
| ![]() |
If an additional drop is needed, or if both eyes are being treated, repeat the steps from 8 to 11.
Do not inject Oftaquix sine into the inner part of the eyeball.
For single use only. Use the eye drops immediately after opening the single-dose container.
The contents of the single-dose container are sufficient for both eyes.
Discard the single-dose container with the remaining solution after single use.
In case of using more Oftaquix sine than recommended, rinse the eye(s) with clean water and inform a doctor or pharmacist.
If a dose of eye drops is missed, use the next dose as soon as remembered. Do not use a double dose to make up for a missed dose.
The amount of levofloxacin in the single-dose container is too small to cause side effects. However, in case of doubt, inform a doctor or pharmacist, who will recommend the necessary measures.
Stopping the use of Oftaquix sine eye drops, solution earlier than recommended by the doctormay prolong the treatment process.
In case of further doubts about the use of this medicine, consult a doctor, pharmacist, or nurse.
Like all medicines, Oftaquix sine can cause side effects, although not everybody gets them.
Most of these side effects affect only the eye and may not last long. If the patient experiences any severe or prolonged side effects, they should stop using Oftaquix sine and seek urgent medical advice.
There is a possibility of an allergic reaction to this medicine.
These symptoms may occur even after a single dose of Oftaquix sine.
In addition, the following may occur:
It is expected that the frequency, type, and severity of side effects in children and adolescents are the same as in adults.
If side effects occur, including any not listed in this leaflet, tell a doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the single-dose container, foil sachet, and carton after "EXP". The expiry date refers to the last day of that month.
The "Lot" abbreviation means batch number.
Containers should be stored in a temperature below 25°C in the original packaging, protected from light.
After opening the sachet, single-dose containers can be stored in the original sachet for 3 months. After this time, discard all unused single-dose containers.
An opened single-dose container with the remaining solution should be discarded immediately after the first use.
Do not use this medicine if there are visible particles in the solution.
Medicines should not be disposed of via wastewater or household waste. Ask a pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Santen Oy
Niittyhaankatu 20
33720 Tampere
Finland
Santen Oy
Kelloportinkatu 1
33100 Tampere
Finland
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Denmark, Finland, Iceland, Italy, Sweden: Oftaquix
Germany, Poland: Oftaquix sine
United Kingdom: Oftaquix Unit Dose
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.